Opioid use disorder
From WikiAnesthesia
Revision as of 11:00, 28 July 2022 by BRANDON ETHAN Sumida (talk | contribs) (Created page with "{{Infobox comorbidity | other_names = | anesthetic_relevance = | specialty = | signs_symptoms = | diagnosis = | treatment = | image = | caption = }} Provide a brief summary of this comorbidity here. == Anesthetic implications<!-- Briefly summarize the anesthetic implications of this comorbidity. --> == === Preoperative optimization<!-- Describe how this comorbidity may influence preoperative evaluation and optimization of patients. --> === Patients with opioid...")
Opioid use disorder
| Anesthetic relevance | |
|---|---|
| Anesthetic management |
{{{anesthetic_management}}} |
| Specialty | |
| Signs and symptoms | |
| Diagnosis | |
| Treatment | |
| Article quality | |
| Editor rating | |
| User likes | 2 |
Provide a brief summary of this comorbidity here.
Anesthetic implications
Preoperative optimization
Patients with opioid use disorder may be on suboxone (buprenorphine-suboxone) as part of an opioid wean plan. Suboxone is a mixed partial agonist-antagonist which is used to prevent symptoms of opiate withdrawal while slowly titrating off other opioid medications.
The dose of suboxone has implications for the risk of opioid tolerance and increased post-operative pain.